{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:23:58Z","timestamp":1791343438587,"version":"4.3.1"},"reference-count":26,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":270,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["095101\/Z\/10Z"],"award-info":[{"award-number":["095101\/Z\/10Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["098381"],"award-info":[{"award-number":["098381"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["G0800467"],"award-info":[{"award-number":["G0800467"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C588\/A19167"],"award-info":[{"award-number":["C588\/A19167"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ZOLEON foundation","award":["no 12.09"],"award-info":[{"award-number":["no 12.09"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:p>At the CDKN2A\/B locus, three independent signals for type 2 diabetes risk are located in a noncoding region near CDKN2A. The disease-associated alleles have been implicated in reduced \u03b2-cell function, but the underlying mechanism remains elusive. In mice, \u03b2-cell\u2013specific loss of Cdkn2a causes hyperplasia, while overexpression leads to diabetes, highlighting CDKN2A as a candidate effector transcript. Rare CDKN2A loss-of-function mutations are a cause of familial melanoma and offer the opportunity to determine the impact of CDKN2A haploinsufficiency on glucose homeostasis in humans. To test the hypothesis that such individuals have improved \u03b2-cell function, we performed oral and intravenous glucose tolerance tests on mutation carriers and matched control subjects. Compared with control subjects, carriers displayed increased insulin secretion, impaired insulin sensitivity, and reduced hepatic insulin clearance. These results are consistent with a model whereby CDKN2A loss affects a range of different tissues, including pancreatic \u03b2-cells and liver. To test for direct effects of CDKN2A-loss on \u03b2-cell function, we performed knockdown in a human \u03b2-cell line, EndoC-bH1. This revealed increased insulin secretion independent of proliferation. Overall, we demonstrated that CDKN2A is an important regulator of glucose homeostasis in humans, thus supporting its candidacy as an effector transcript for type 2 diabetes\u2013associated alleles in the region.<\/jats:p>","DOI":"10.2337\/db15-0602","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T04:09:25Z","timestamp":1446782965000},"page":"527-533","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":54,"title":["Loss-of-Function Mutations in the Cell-Cycle Control Gene <i>CDKN2A<\/i> Impact on Glucose Homeostasis in Humans"],"prefix":"10.2337","volume":"65","author":[{"given":"Aparna","family":"Pal","sequence":"first","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Potjer","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren K.","family":"Thomsen","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Jin","family":"Ng","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Barrett","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Scharfmann","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Timothy","family":"Bishop","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Karpe","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."},{"name":"Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Godsland","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans F.A.","family":"Vasen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Newton-Bishop","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Pijl","sequence":"additional","affiliation":[{"name":"Leiden University Medical Centre, Department of Internal Medicine, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."},{"name":"Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, U.K."},{"name":"Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Gloyn","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K."},{"name":"Oxford National Institute for Health Research Biomedical Research Centre, Churchill Hospital, Oxford, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"2022031303541935000_B1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","article-title":"Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis","volume":"42","author":"Voight","year":"2010","journal-title":"Nat Genet"},{"key":"2022031303541935000_B2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"key":"2022031303541935000_B3","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.2337\/db07-0856","article-title":"Studies of association of variants near the HHEX, CDKN2A\/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies","volume":"56","author":"Grarup","year":"2007","journal-title":"Diabetes"},{"key":"2022031303541935000_B4","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/db13-0949","article-title":"Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity","volume":"63","author":"Dimas","year":"2014","journal-title":"Diabetes"},{"key":"2022031303541935000_B5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"2022031303541935000_B6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"2022031303541935000_B7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"2022031303541935000_B8","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/sj.onc.1205429","article-title":"Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways","volume":"21","author":"Weber","year":"2002","journal-title":"Oncogene"},{"key":"2022031303541935000_B9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05092","article-title":"p16INK4a induces an age-dependent decline in islet regenerative potential","volume":"443","author":"Krishnamurthy","year":"2006","journal-title":"Nature"},{"key":"2022031303541935000_B10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/8751","article-title":"Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia","volume":"22","author":"Rane","year":"1999","journal-title":"Nat Genet"},{"key":"2022031303541935000_B11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13267","article-title":"Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression","volume":"510","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"2022031303541935000_B12","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2337\/db13-1921","article-title":"Cdkn2a\/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1\u03b1 pathway","volume":"63","author":"Bantubungi","year":"2014","journal-title":"Diabetes"},{"key":"2022031303541935000_B13","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1038\/sj.onc.1206506","article-title":"Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number","volume":"22","author":"Mart\u00edn","year":"2003","journal-title":"Oncogene"},{"key":"2022031303541935000_B14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2337\/db08-0631","article-title":"Survey of the human pancreatic beta-cell G1\/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo","volume":"58","author":"Fiaschi-Taesch","year":"2009","journal-title":"Diabetes"},{"key":"2022031303541935000_B15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/db09-1776","article-title":"Induction of human beta-cell proliferation and engraftment using a single G1\/S regulatory molecule, cdk6","volume":"59","author":"Fiaschi-Taesch","year":"2010","journal-title":"Diabetes"},{"key":"2022031303541935000_B16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1439824","article-title":"Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22","volume":"258","author":"Cannon-Albright","year":"1992","journal-title":"Science"},{"key":"2022031303541935000_B17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/humu.9247","article-title":"Familial melanoma, pancreatic cancer and germline CDKN2A mutations","volume":"23","author":"Goldstein","year":"2004","journal-title":"Hum Mutat"},{"key":"2022031303541935000_B18","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.1152\/ajpendo.00328.2004","article-title":"Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis","volume":"291","author":"Godsland","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303541935000_B19","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1172\/JCI58447","article-title":"A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion","volume":"121","author":"Ravassard","year":"2011","journal-title":"J Clin Invest"},{"key":"2022031303541935000_B20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI108047","article-title":"Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood","volume":"55","author":"Horwitz","year":"1975","journal-title":"J Clin Invest"},{"key":"2022031303541935000_B21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/humu.21245","article-title":"Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A","volume":"31","author":"McKenzie","year":"2010","journal-title":"Hum Mutat"},{"key":"2022031303541935000_B22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1747.1998.00211.x","article-title":"Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions","volume":"110","author":"Keller-Melchior","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2022031303541935000_B23","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031303541935000_B24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tem.2015.01.008","article-title":"Functional genomics of the CDKN2A\/B locus in cardiovascular and metabolic disease: what have we learned from GWASs","volume":"26","author":"Hannou","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"2022031303541935000_B25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2870","article-title":"Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants","volume":"46","author":"Pasquali","year":"2014","journal-title":"Nat Genet"},{"key":"2022031303541935000_B26","doi-asserted-by":"crossref","first-page":"13924","DOI":"10.1073\/pnas.1402665111","article-title":"Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism","volume":"111","author":"Fadista","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db15-0602","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/65\/2\/527\/580877\/db150602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/2\/527\/580877\/db150602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:47:28Z","timestamp":1667407648000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/2\/527\/40138\/Loss-of-Function-Mutations-in-the-Cell-Cycle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,11,5]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db15-0602","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}